SLCO1B1 and cancer: Several studies used similar approaches and compared the results from both flow cytometry and mass spectrometry in Immunological studies for monitoring of human cancer clinical trials [50], quantifying markers for diagnosis of Alzheimer’s [51], and measuring human hepatic transporter P-gp and OATP1B1 in hepatocytes [52].